Jeffrey Strovel

CEO Irazu Oncology | @ Jeffrey Strovel, PhD | Drug Discovery & Development

Role
Chief Executive Officer at Irazu Oncology
Location
Laurel, MD, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Jeffrey Strovel

Dynamic BioPharma Executive and Scientific Leader leveraging a distinguished career…

Experience

  1. Chief Executive Officer

    Irazu Oncology

    Mar 2024 — Present · Baltimore, MD, US

Education

  • University of Maryland School of Medicine

    PhD

    1994 — 1999

  • University of Maryland Baltimore

    Ph.D.

    1994 — 1999

  • West Virginia University

    Bachelor of Science

    1987 — 1989

Skills

  • Cell
  • Biomarker Discovery
  • Gene Expression Profiling
  • In Vivo
  • Fluorescence
  • Technology Transfer
  • Genomics
  • Biomarkers
  • Life Sciences
  • Science
  • Lifesciences
  • Computational Biology
  • Protein Chemistry
  • Cell Biology
  • Drug Development
  • Elisa
  • Cancer
  • Molecular Biology
  • Translational Medicine
  • Biotechnology
  • Flow Cytometry
  • Oncology
  • Toxicology
  • High Throughput Screening
  • Clinical Development
  • Drug Discovery
  • Pharmacology
  • Cell Culture
  • Bioinformatics
  • Immunology
  • Assay Development
  • Genetics
  • Proteomics
  • Vaccines
  • In Vitro

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Jeffrey Strovel — Chief Executive Officer at Irazu Oncology in Laurel, MD, US | Unifers